Sotera Health Company (NASDAQ:SHC) Receives $20.25 Consensus Target Price from Analysts

Shares of Sotera Health Company (NASDAQ:SHC) have been assigned a consensus rating of “Moderate Buy” from the eleven analysts that are covering the company, Marketbeat Ratings reports. Three equities research analysts have rated the stock with a hold rating and eight have issued a buy rating on the company. The average 1-year target price among brokerages that have updated their coverage on the stock in the last year is $21.50.

Several brokerages have weighed in on SHC. Piper Sandler reissued an “overweight” rating and set a $25.00 price objective (up from $22.00) on shares of Sotera Health in a report on Friday, August 7th. Weiss Ratings upgraded Sotera Health from a “hold (c)” rating to a “hold (c+)” rating in a research note on Tuesday. Barclays upped their price target on Sotera Health from $19.00 to $22.00 and gave the company an “overweight” rating in a research report on Friday, August 7th. UBS Group set a $19.00 price objective on Sotera Health in a report on Wednesday, June 24th. Finally, JPMorgan Chase & Co. boosted their price objective on Sotera Health from $16.00 to $18.00 and gave the company a “neutral” rating in a research note on Friday, August 7th.

Insiders Place Their Bets

In other news, insider Michael P. Rutz sold 150,000 shares of Sotera Health stock in a transaction dated Friday, August 7th. The shares were sold at an average price of $18.84, for a total value of $2,826,000.00. Following the completion of the transaction, the insider owned 334,279 shares in the company, valued at $6,297,816.36. This trade represents a 30.97% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. 15.36% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently bought and sold shares of the business. BlackRock Inc. purchased a new stake in shares of Sotera Health during the second quarter worth $428,635,000. Sculptor Capital LP raised its stake in shares of Sotera Health by 57.4% during the 4th quarter. Sculptor Capital LP now owns 21,000,000 shares of the company’s stock valued at $370,440,000 after purchasing an additional 7,658,200 shares during the period. Two Seas Capital LP purchased a new stake in Sotera Health during the 2nd quarter worth about $103,590,000. Sachem Head Capital Management LP boosted its stake in Sotera Health by 47.2% in the 4th quarter. Sachem Head Capital Management LP now owns 11,645,000 shares of the company’s stock worth $205,418,000 after purchasing an additional 3,735,000 shares during the period. Finally, Vanguard Group Inc. boosted its stake in Sotera Health by 16.7% in the 4th quarter. Vanguard Group Inc. now owns 19,228,375 shares of the company’s stock worth $339,189,000 after purchasing an additional 2,756,583 shares during the period. 91.03% of the stock is owned by institutional investors.

Sotera Health Stock Performance

Shares of SHC stock opened at $18.89 on Thursday. The company has a debt-to-equity ratio of 3.33, a quick ratio of 2.55 and a current ratio of 2.80. The firm has a market cap of $5.39 billion, a price-to-earnings ratio of 33.14 and a beta of 1.77. Sotera Health has a 52 week low of $13.09 and a 52 week high of $19.85. The firm’s 50-day simple moving average is $17.35 and its two-hundred day simple moving average is $16.31.

Sotera Health (NASDAQ:SHC) last released its earnings results on Thursday, August 6th. The company reported $0.26 earnings per share for the quarter, beating analysts’ consensus estimates of $0.24 by $0.02. Sotera Health had a net margin of 13.44% and a return on equity of 40.12%. The firm had revenue of $321.38 million during the quarter, compared to the consensus estimate of $309.70 million. During the same period in the prior year, the firm earned $0.20 EPS. The company’s revenue was up 9.2% compared to the same quarter last year. Sotera Health has set its FY 2026 guidance at 0.950-1.010 EPS. As a group, equities analysts forecast that Sotera Health will post 0.87 earnings per share for the current year.

Sotera Health Company Profile

Sotera Health Inc (NASDAQ: SHC) is a global provider of sterilization and laboratory testing services that support the medical device, pharmaceutical, life sciences and consumer product industries. Headquartered in Jacksonville, Florida, the company offers a suite of services designed to ensure products meet rigorous safety and regulatory requirements before reaching market.

Sotera Health operates through three primary service platforms. Its Sterigenics division delivers contract sterilization solutions, including ethylene oxide (EtO), gamma irradiation, electron beam and X-ray technologies.